← All stocks

ARVINAS, INC.

ARVN No buying or selling

CIK 0001655759 #2976 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

15 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Houston John G

Director

—

1,122,183

$9.16M

+8.2%

Teel Randy

President and CEO

—

285,009

$2.33M

+80.1%

Berkowitz Noah

Chief Medical Officer

—

191,395

$1.56M

+201.6%

Saik Andrew

Chief Financial Officer

—

187,432

$1.53M

+205.2%

Cacace Angela M

Chief Scientific Officer

—

180,390

$1.47M

+234.5%

Taylor Ian

President, R&D

—

159,121

$1.30M

+7.9%

Morrison Briggs

Director

—

111,548

$910.12K

+271.9%

Kennedy Edward Moore Jr.

Director

—

54,957

$448.39K

+134.8%

Norwalk Leslie V

Director

—

41,572

$339.19K

+314.9%

Cunningham Everett

Director

—

41,572

$339.19K

+314.9%

Smaldone Alsup Laurie

Director

—

41,572

$339.19K

+314.9%

Bain Linda

Director

—

41,572

$339.19K

+314.9%

Loomis David K

VP, Chief Accounting Officer

—

40,193

$327.93K

+262.7%

AGARWAL SUNIL

Director

—

30,166

$246.12K

+113.3%

YOUNG JOHN D

Director

—

26,045

$212.50K

+159.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 28 Sep 2018